Implication of Leumorphin in Inhibitory Control of Vasopressin Secretion in Conscious Rats

The effects of leumorphin, a K-agonist derived from proenkephalin B (neoendorphin and dynorphin precursor), on vasopressin secretion were studied under basal and stimulated conditions in conscious, unrestrained rats. Intracerebroventricular injection of leumorphin (60 or 600 pmol) significantly inhibited basal vasopressin secretion. The vasopressin response induced by intracerebroventricular injection of angiotensin II (100 pmol) was significantly suppressed, hi a dose-dependent fashion, by the simultaneous intracerebroventricular injection of leumorphin (6, 60, or 600 pmol). Intravenous pretreatment with naloxone (0.5 mg/kg body weight) diminished the inhibitory action of leumorphin (60 pmol) on vasopressin secretion. Moreover, naloxone (0.5 mg/kg body weight) prolonged the vasopressin secretion induced by intracerebroventricular injection of angiotensin II (100 pmol). These results indicate that leumorphin possesses a potent inhibitory effect on vasopressin secretion and that, alone or in combination with other endogenous opioid peptides, it plays an important role hi the control of vasopressin secretion.

[1]  J. Haaf,et al.  Dynorphin-(1-13) is a potent in vivo suppressor of vasopressin levels in the rat. , 1987, Acta endocrinologica.

[2]  M. E. Lewis,et al.  Pharmacological and anatomical evidence of selective μ, δ, and χ opioid receptor binding in rat brain , 1986, Brain Research.

[3]  H. Imura,et al.  Centrally Infused Atrial Natriuretic Polypeptide Attenuates Exaggerated Salt Appetite in Spontaneously Hypertensive Rats , 1986, Circulation research.

[4]  H. Itoh,et al.  Central effect of atrial natriuretic polypeptide on angiotensin II-stimulated vasopressin secretion in conscious rats. , 1986, European journal of pharmacology.

[5]  D. de Wied,et al.  Effect of the opioid peptide beta-endorphin on the in vivo release of vasopressin in rats under various conditions. , 1986, Neuroendocrinology.

[6]  K. Nakao,et al.  Potent action of leumorphin on consummatory behaviors in rats: comparison with other opioid peptides. , 1986, Neuroendocrinology.

[7]  H. Itoh,et al.  Centrally administered leumorphin possesses potent depressor activity in conscious rats. , 1986, NIDA research monograph.

[8]  S. Watson,et al.  Coordinate expression of hypothalamic pro-dynorphin and pro-vasopressin mRNAs with osmotic stimulation. , 1986, Neuroendocrinology.

[9]  N. Barden,et al.  Dynorphin 1-8 binds to opiate kappa receptors in the neurohypophysis. , 1986, Neuroendocrinology.

[10]  M. E. Lewis,et al.  Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain. , 1986, Brain research.

[11]  K. Nakao,et al.  Endogenous opioids and related peptides: from molecular biology to clinical medicine. The Sir Henry Dale lecture for 1985. , 1985, The Journal of endocrinology.

[12]  K. Nakao,et al.  Leumorphin in human brain , 1985, Neuropeptides.

[13]  K. Nakao,et al.  Leumorphin is a novel endogenous opioid peptide in man. , 1984, Biochemical and biophysical research communications.

[14]  K. Nakao,et al.  A novel opioid peptide, leumorphin, acts as an agonist at the κ opiate receptor , 1983 .

[15]  H. Imura,et al.  Synthesis of porcine leumorphin and some of its biological activities , 1983, Regulatory Peptides.

[16]  Shigetada Nakanishi,et al.  Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor , 1982, Nature.

[17]  H. Akil,et al.  Dynorphin and vasopressin: common localization in magnocellular neurons. , 1982, Science.

[18]  G. Hertting,et al.  Vasopressin and beta-endorphin release after osmotic and non-osmotic stimuli: effect of naloxone and dexamethasone. , 1982, European journal of pharmacology.

[19]  L. Keil,et al.  Opiate regulation of angiotensin-induced drinking and vasopressin release. , 1981, The Journal of pharmacology and experimental therapeutics.

[20]  G. Hertting,et al.  Naloxone promotes stimulus-evoked vasopressin release in vivo. , 1980, European journal of pharmacology.

[21]  J. M. Ree,et al.  Effects of morphine and β-endorphin on basal and elevated plasma levels of α-MSH and vasopressin , 1979 .